tirzepatide more effective than semaglutide caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide The infographic compares 10 commonly

CONVENIENT APPLICATION: Apply patches to clean, dry skin in seconds for seamless botanical infusion into your daily ritual

Areas with thicker skin, like the backs of hands, elbows, and knees, can potentially tolerate higher concentrations

Its generally taken once or twice daily for 90 days

143 The safety profile of tirzepatide is similar to other drugs in its class, providing an effective new treatment option for patients with T2DM and obesity

Pure Hydration Simply rehydrate and restore fluid balance

Acute Pancreatitis Incidence in Patients Initiating Glucagon-Like Peptide-1 Receptor Agonists for Obesity in a Large US Health Care System